Compare · 2 funds side by side · dividends reinvested

CURE and TECL

CUREDirexion×TECLDirexion×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$26,007TECL · best of the two

02 / 04

CURE and TECL, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

Direxion Daily Healthcare Bull 3X ETFLeveraged · 3x0.94%0.76%+49.8%+82.5%+31.0%+7.8%−31.1%48.0%$200M1.4

Direxion Daily Technology Bull 3X ETFLeveraged · 3x0.94%5.22%+39.9%+18.4%+63.7%+21.1%−45.3%82.2%$4.5B1.5

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 3, 2026 · returns include dividends · since: CURE 2011 · TECL 2008

Head to Head

Swap sides Versus in desk

Head to Head

Direxion Daily Healthcare Bull 3X ETF · $200M$14,551

CURE

TECL

Direxion Daily Technology Bull 3X ETF · $4.5B$26,007

$10,000 five years ago, dividends reinvested · they hold 0.0% in common

CUREMeasureTECL

+49.8%Year to dateJan 1 → Nov 3+39.9%

+82.5%1 yearTotal return+18.4%

+31.0%3 years · per year$10,000 became $22,495 · $43,896+63.7%

+7.8%5 years · per year$10,000 became $14,551 · $26,007+21.1%

0.94%Expense ratio$94 · $94 a year on $10k · lower is better0.94%

0.76%Trailing 12-mo yield$76 · $522 a year on $10k5.22%

−31.1%Worst dropSmaller is better−45.3%

48.0%VolatilityLower is calmer82.2%

CURETECL Winner of the row, in its colourEach row: the bigger of the two fills its side

4–3CURE wins

End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

CURE vs TECL: Top 5 Holdings

Today

CURE

9.4%in top 5

TECL

in top 510.1%

CUREStockTECL

3.5%LLYnot top 5

not top 5AAPL3.0%

not top 5NVDA3.0%

not top 5MSFT2.3%

2.0%JNJnot top 5

1.6%ABBVnot top 5

1.1%MRKnot top 5

1.1%UNHnot top 5

not top 5AVGO0.9%

not top 5AMD0.8%

Held in common0.0%

End-of-day Nov 3, 2026 · share of each fund

CURE vs TECL Returns, Every Period

DirexionCURE

+7.8%

5 years, per year

TECLDirexion

+21.1%

5 years, per year

CURETECLFaded: behind in that period

2–2Level

End-of-day Nov 3, 2026 · dividends in · faded = behind in that period

CURE vs TECL

YTD

DirexionCURE

+49.8%

TECLDirexion

+39.9%

+49.8%Year to date+39.9%

−31.1%Worst drop · 1Y−45.3%

48.0%Volatility · 1Y82.2%

0.8%Yield5.2%

$200MAssets$4.5B

3–1CURE wins

End-of-day Nov 3, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: CURE, TECL

Today

0.94%lowest, CURE

FundExpense ratioFee$10k

CURE0.94%$94

TECL0.94%$94

End-of-day Nov 3, 2026 · fee on $10,000 a year

Yields: CURE, TECL

5.22%highest, TECL

FundTrailing yieldYield$10k

TECL5.22%$522

CURE0.76%$76

End-of-day Nov 3, 2026 · trailing 12-month yield

Income After Fees on $10,000

$428most kept, TECL

TECL$522 − $94 = $428

CURE$76 − $94 = −$18

KeptFee

End-of-day Nov 3, 2026 · yield in dollars minus the fee

Overlap: CURE, TECL

Today

0.0%most shared, CURE and TECL

CURETECL

CURE—0.0%

TECL0.0%—

End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+82.5%CURE, at 48.0% volatility

CUREWorst drop−31.1%48.0% vol

TECLWorst drop−45.3%82.2% vol

End-of-day Nov 3, 2026 · up and left is better

Paid More vs Made More

YTD

TECLCURE

+39.9%Year to date+49.8%

5.2%Yield0.8%

+18.4%Past year+82.5%

0.94%Fee0.94%

2–1CURE wins

End-of-day Nov 3, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+32.8%

VIGVanguard

+14.0%

+32.8%Year to date+14.0%

3.0%Yield1.5%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 3, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+7.5%

JEPIJ.P. Morgan

+7.0%

+7.5%Year to date+7.0%

12.3%Yield8.0%

$41.8BAssets$46.0B

2–0JEPQ wins

End-of-day Nov 3, 2026

SPYM vs SPY

YTD

SPDRSPYM

+11.5%

SPYSPDR

+11.5%

+11.5%Year to date+11.5%

1.0%Yield1.0%

$185BAssets$798B

0–0level

End-of-day Nov 3, 2026